7 The role of MUC18 in prostate carcinoma

Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas

Volumn 2, Issue , 2002, Pages 347-358

  Wu, Guang Jer ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649363642     PISSN: 18745784     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5784(02)80039-3     Document Type: Article

References (33)

1. Allan E.N., Luanda M.E., and Abel P.D. Molecular and cellular biology of prostate cancer. Cancer and Metas. Rev. 16 (1997) 29-66
2. Bernstein S.C., and Weinberg R.A. Expression of the metastatic phenotype of cells transfected with human metastatic tumor DNA. Proc. Natl. Acad. Sci. USA 82 (1985) 1726-1730
3. Bonkhoff H., and Remberger K. Differentiation pathways and histogenic aspects of normal and abnormal prostatic growth: A stem cell model. Prostate 28 (1996) 98-106
4. Brawley O.W., and Kramer B.S. The epidemiology and prevention of prostate cancer. In: Dawson N.A., and Vogelzang N.J. (Eds). Prostate Cancer (1994), Wiley-Liss, John Wiley & Sons, Inc., New York 47-64
5. Catalona W.J., and Scott W.W. Carcinoma of the prostate; a review. J. Urol. 119 (1978) 1-8
6. Chambers A.F., MacDonald I.C., Schmidt E.E., Koop S., Morris V.L., Khokha R., and Groom A.C. Step in tumor metastasis: New concepts from intravital video microscopy. Cancer Metastasis Rev. 14 (1995) 279-301
7. De Marzo A.M., Nelson W.M., Meeker A.K., and Coffey D.S. Stem cell features of benign and malignant prostate epithelial cells. J. Urol. 160 (1998) 2381-2392
8. DiSant' Agnese P.A. Neuroendocrine differentiation in human prostatic carcinoma. Human Path. 23 (1992) 287-296
9. Edlund M., Miyamoto T., Sikes R.A., Ogle R., Laurie G.W., Farach-Carson M.C., Otey C.A., Zhau H.E., and Chung L.W.K. Integrin expression and usage by prostate cancer cell lines on laminin substrata. Cell Growth Diff. 12 (2001) 99-107
10. Foster B. New paradigms for prostate cancer research-TRAMP bone metastasis cell lines. Proceedings of the AACR special conference: New discoveries in prostate cancer biology and treatment. At The Registry Resort, Naples, FL, Dec 5-9, 2001 (2001)
11. Gao A.C., Lou W., Dong J.T., and Isaacs J.T. CD44 is a metastasis suppressor gene for prostate cancer located on human chromosome 11pl3. Cancer Res. 57 (1997) 846-849
12. Grayhack J.T., Kozlowski J.M., and Lee C. The pathogenesis of benign prostatic hyperplasia: A proposed hypothesis and critical evaluation. J. Urol 160 (1998) 2375-2380
13. Greenberg N.M., DeMayo F., Finegold M.J., Medina D., Tilley W.D., Aspinall J.O., Cunha G.R., Donjacour A.A., Matusik R.J., and Rosen J.M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 92 (1995) 3439-3443
14. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 10-57
15. Herlyn M. Molecular and Cellular Biology of Melanoma (1993), R.G. Landes Co., Austin, TX 1-97
16. Kleinerman D.I., Zhang W., Lin S., Van N.T., von Eschenbach A.C., and Hsieh J.T. Application of a tumor suppressor (C-CAMl)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: A preclinical study. Cancer Res. 55 (1995) 2831-2836
17. Lehmann J.M., Reithmuller G., and Johnson J.P. MUC18, a marker of tumor progression in human melanoma. Proc. Natl. Acad. Sci. USA 86 (1989) 9891-9895
18. Lengauer C., Kinzler K.W., and Vogelstien B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
19. Mohler J.L. Cellular motility and prostate carcinoma metastases. Cancer Metastasis Rev. 12 (1993) 53-67
20. Putz E., Witter K., Offner S., Stosiek P., Zippeliux A., Johnson J., Zahn R., Reithmuller G., and Pantel K. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of work. Cancer Res. 59 (1999) 241-248
21. Richie J.P., and Kaplan I.D. Screening for prostate cancer: the horns of a dilemma. In: Kantoff P.W., Wishnow K.I., and Loughlin K.R. (Eds). Prostate Cancer: A Multidisciplinary Guide (1997), Blackwell Science Inc., Malde, MA 1-10
22. Ruddon R.W. Chapter 11: Biology of tumor metastasis. Cancer Biology, 3rd ed. (1995), Oxford University Press, New York and Oxford 402-427
23. Shih I.M., Nesbit M., Herlyn M., and Kurman R.J. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. Mod. Pathol. 11 (1998) 1098-1106
24. Umbas R., Schalken J.A., Aalders T.W., Carter B.S., Karthaus H.F.M., Schaafsma H.E., Debruyene F.M.J., and Isaacs W.B. Expression of the cellular adhesion molecules E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 52 (1992) 5104-5109
25. Weiss L. Metastatic inefficiency. Adv. Cancer Res. 54 (1990) 159-211
26. Wood Jr. D.P., Banks E.R., Humphreys S., McRoberts J.W., and Rangneker V.M. Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 74 (1994) 2533-2540
27. #298. Wu G.J., Chiang C.F., Fu P., Wang S.W.C., Hess W., Greenberg N., and Wu M.W.H. Correlation of MUC18 expression with the malignant progression of mouse prostate adenocarcinoma in the TRAMP mice. Proceedings of the 94th Annual Meeting of American Association for Cancer Research 44 (2003) 16
28. Wu G.J., Peng Q., Fu P., Wang S.W.C., Chiang C.F., Dillehay D.L., and Wu M.W.H. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells. Gene 327 (2004) 201-213
29. Abstract # 2776. Wu G.J., Peng Q., Wang S.W., Yang H., and Wu M.W.H. Effect of MUC18 expression on the in vitro invasiveness and in vivo tumorigenesis and metastasis of mouse melanoma cell lines in a syngeneic mouse model. Proceedings of the 92nd Annual Meeting of American Association for Cancer Research 42 (2001) 516
30. Wu G.J., Wu M.W.H., Wang S.W., Liu Z., Peng Q., Qu P., Yang H., Varma V.A., Sun Q., Petros J.A., Lim S., and Amin M.B. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cells and tissues with m. Gene 279 (2001) 17-31
31. Xie S., Luca M., Huang S., Gutman M., Reich R., Johnson J.P., and Bar-Eli M. Expression of MCAM/MCU18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res. 57 (1997) 2295-2303
32. Zheng D.Q., Woodard A.S., Fornaro M., Tallini G., and Languino L.R. Prostatic carcinoma cell migration via αVβ3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res. 59 (1999) 1655-1664
33. Zutter M.M., Santoro S.A., Staatz W.D., and Tsung Y.L. Re-expression of the α2βl integrin abrogates the malignant phenotype of breast carcinoma cells. Proc. Natl. Acad. Sci. USA 92 (1995) 7411-7415